Schroit A J, Madsen J, Nayar R
Chem Phys Lipids. 1986 Jun-Jul;40(2-4):373-93. doi: 10.1016/0009-3084(86)90080-0.
The interactions of liposomes with cells have been extensively studied to determine their potential use as vehicles for the delivery of drugs in vivo. Since intravenously administered liposomes are, for the most part, cleared by cells of the reticuloendothelial system (RES), considerable effort has been made to take advantage of this phenomenon rather than view it as an obstacle. Indeed, cells of the RES, in particular macrophages, have been shown to play a vital role in homeostasis and in host defence mechanisms against infection and neoplasia. In this article, we present an overview of liposome-cell interactions, with particular emphasis on the techniques used to monitor the interaction of liposomes with macrophages. Specifically, we discuss methodologies which can be used to differentiate between liposome-cell fusion, adsorption and endocytosis in vitro. In addition, we outline the various strategies that have been employed for both actively and passively targeting liposomes to macrophages in vivo. We also review the rationale and various techniques for designing liposomes for enhanced macrophage uptake, which, in certain cases, results in the selective release of liposome-entrapped compounds in situ.
脂质体与细胞的相互作用已得到广泛研究,以确定其作为体内药物递送载体的潜在用途。由于静脉注射的脂质体大部分会被网状内皮系统(RES)的细胞清除,人们已付出相当大的努力来利用这一现象,而非将其视为障碍。事实上,RES的细胞,特别是巨噬细胞,已被证明在体内稳态以及宿主抗感染和肿瘤的防御机制中发挥着至关重要的作用。在本文中,我们概述了脂质体与细胞的相互作用,特别强调了用于监测脂质体与巨噬细胞相互作用的技术。具体而言,我们讨论了可用于在体外区分脂质体与细胞融合、吸附和内吞作用的方法。此外,我们概述了在体内将脂质体主动和被动靶向巨噬细胞所采用的各种策略。我们还回顾了设计脂质体以增强巨噬细胞摄取的原理和各种技术,在某些情况下,这会导致脂质体包裹的化合物在原位选择性释放。